Navigation Links
Leeds researchers reshape the future of drug discovery
Date:11/18/2008

Co-researcher Dr Stuart Warriner added: "Making molecules is a bit like making something using lego bricks. Up until now we've only really become good at making, say, the equivalent of a lego car or train. There might be 30 million synthetic molecules registered, but there's probably several million of these that are the equivalent of lego cars they may have different wheels and wing mirrors, but their fundamental shape is essentially the same. We've not really scratched the surface of the possible structures that could be made. This lack of variety in the core shape of molecules may well limit the range of proteins that medicinal chemists can target."

The Leeds approach makes use of 'metathesis', a reaction that won the 2005 Nobel Prize in Chemistry.

Explains Professor Nelson: "We take simple building blocks, a bit like the amino acids that make up peptides, and we assemble them in different sequences using three simple reactions to link them together in a chain. The key difference is that we then add the catalyst which initiates a 'scaffold reprogramming reaction', which ripples down the chemical chain and restitches the molecule together in a completely different way each time.

"It's a bit like a molecular square dance, where atoms in the molecule swap partners - and the exciting thing is that we can change the building blocks again and again in different combinations as a really powerful way to vary the core frameworks that result. The potential of this process is enormous," he says.

The team from Leeds have used their approach to prepare molecules with 84 distinct molecular frameworks and about two-thirds of the frameworks are unprecedented in the history of organic chemistry. The work is a huge leap forward from landmark research reported in 2003, which resulted in the creation of six frameworks in a single process. It is also a significant improvement on more recent research in which around 30 frameworks were created
'/>"/>

Contact: Professor Adam Nelson
a.s.nelson@leeds.ac.uk
44-011-334-36502
University of Leeds
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Leeds medics solve an ancient riddle -- and offer new tool for diagnosis
2. UNC researchers find clue to stopping breast-cancer metastasis
3. U of U researchers to use patients own stem cells to treat heart failure
4. Researchers identify toehold for HIVs assault on brain
5. Researchers Tackle CLL, Diabetes and Trauma-Hemorrhage
6. Researchers Use New Method to Control Bleeding in Hemophilia
7. Stem cells with potential to regenerate injured liver tissue identified by Penn researchers
8. Protein can nurture or devastate brain cells, depending on its friends, researchers find
9. Researchers find stem cells from monkey teeth can stimulate growth and generation of brain cells
10. Battling Bacteria in the Blood: U-M Researchers Tackle Deadly Infections
11. Researchers to Present Additional Data on Soliris(R) (eculizumab) for the Treatment of PNH at the ASH Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Children's Hospital Surgeon Receives Prestigious Paul Tessier Medal 2Health News:Physical Therapist, Money Launderer and Patient Recruiter Plead Guilty in Connection With Multiple Detroit Health Care Fraud Schemes 2Health News:Physical Therapist, Money Launderer and Patient Recruiter Plead Guilty in Connection With Multiple Detroit Health Care Fraud Schemes 3Health News:Physical Therapist, Money Launderer and Patient Recruiter Plead Guilty in Connection With Multiple Detroit Health Care Fraud Schemes 4Health News:Authentidate Holding Corp. Completes Capital Raise 2Health News:Authentidate Holding Corp. Completes Capital Raise 3Health News:Happy Feet are Healthy Feet: Common Sense Tips on Taking Care of Your Feet to Survive the Holiday Season 2Health News:Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange 2Health News:Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange 3